Ranbaxy Laboratories Reports Loss

Ranbaxy Laboratories RBXZF reported a loss in the quarter ended March 31. Ranbaxy posted a quarterly after-tax loss of 736.5 million rupees ($12.26 million). Its drug sales climbed to 24.4 billion rupees, versus 24.1 billion rupees, in the year-earlier period. Its US sales jumped to 7.7 billion rupees versus 5.9 billion rupees.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsloss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!